Global Nasogastric Tube Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Nasogastric Tube Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Nasogastric Tube refers to a tube that is passed through the nose and down through the nasopharynx and esophagus into the stomach. It is a flexible tube made of rubber or plastic, and it has bidirectional potential. It can be used to remove the contents of the stomach, including air, to decompress the stomach, or to remove small solid objects and fluid, such as poison, from the stomach. An NG tube can also be used to put substances into the stomach, and so it may be used to place nutrients directly into the stomach when a patient cannot take food or drink by mouth.

Nasogastric tubes (NGT) still remain the simple and best way for the gastrointestinal tract access. The NGT placing is one of the most commonly performed procedures in emergency medical cases. NG tube passes through the nose and down the nasopharynx and esophagus into the stomach. The tube can be used to remove the contents of the stomach and deliver the important nutritional and medicinal support to ill patients. Premature and sick babies have a limited supply of energy and nutrients. The NG tubes deliver the nutrients and medicinal support in these emergency cases. Moreover, many critical conditions associated with swallowing disorders such as dementia, amyotrophic lateral sclerosis, neurological diseases, physical obstruction, and stroke require NG tubes to provide nutritional and medicinal support for ill patients.

Market Overview:

The latest research study on the global Nasogastric Tube market finds that the global Nasogastric Tube market reached a value of USD 267.76 million in 2022. It’s expected that the market will achieve USD 332.77 million by 2028, exhibiting a CAGR of 3.69% during the forecast period.

Upstream and downstream interactions will lead to disruption of business

The epidemic will have a short-term impact on nasogastric tube industry, but it is relatively limited. Due to the impact of the epidemic, the production of raw materials and equipment procurement and transportation supply are difficult to be in place, and upstream enterprises affect the work schedule of downstream enterprises. Equipment manufacturing and product manufacturing enterprises in nasogastric tube industry are affected to different degrees, and the production and delivery work may be delayed to some extent. Meanwhile, if it fails to meet the customer's delivery time requirements according to the contract, it may lead to the customer looking for another enterprise and lose business. Apart from this, the COVID-19 outbreak has resulted in the closing down of several manufacturing facilities across the globe. The pandemic caused huge revenue losses in end-use industry. The coronavirus lockdown put a brake on the production of several key raw materials in the global market, which, in turn, spiked the prices and lowered the demand for the product. The strict lockdown mandates imposed by governments have restricted cross-border trade between countries, another factor proving to be detrimental for the nasogastric tube market share. In addition, nasogastric tube manufacturers are drawing up plans for the international market as a new supply link in the global nasogastric tube industry, as companies look to re-engineer supply chains in the aftermath of COVID-19. Also, it is expected that the product demand in end-user sectors could pick up following the uplift of the lockdown in numerous countries.

Affect the normal operation of the industry

The impact of COVID-19 on the nasogastric tube industry will involve all major links and all entities in the industry chain. The company's management efficiency has declined, commuting has been severely hindered, production plans have been severely hindered, network expansion has been delayed, marketing has been delayed, brand adjustments have been forced, market sales have declined, and company and employee revenue have declined. The government has also put forward higher requirements for the production and operation of enterprises. Although various industries around the world are gradually resuming work, production and demand will not pick up rapidly and substantially, and will require a certain recovery period.

Strength

The global nasogastric tube market is foreseen to attain growth while riding on increasing chronic disease rates, rise in the number of preterm births, and expanding geriatric population base. Factors driving the growth of the market are; growing demand from nutritional support to children and adult patients and increasing number of hospitalized pediatric and geriatric patients. Moreover, increasing number of premature baby births and growing number of neck and facial surgeries is further propelling the market growth. The demand for nasogastric tubes will spur over the forthcoming years owing to rising incidence of chronic diseases. The most common enteral feeding tube used in hospitalized children is a nasogastric tube that is placed through the nostril, through the esophagus and finally into the stomach. Pediatric and geriatric hospitalized patients constantly require a nasogastric tube embedded for the purpose of controlling enteral feeding, medications or for gastric decompression. Thus, the growing number of hospitalizations among pediatric and geriatric population base will offer lucrative opportunities for nasogastric tube market growth in the projected timeframe.

Weakness

Developmental delays and side effects such as skin irritation, tube dislocation, tube perforation, gagging, and retching could negatively affect market growth for nasogastric tube. Moreover, concerns regarding side effects such as skin irritation, abdominal cramping, and tube dislocation may hamper the market growth to some extent.
Restrains including occurrence of skin irritation and infections due to nasogastric procedures caused by improper sterilization, tube dislocation can impede the market growth. Barriers such as vigorous suction due to nasogastric tubes, that may damage the gastric mucosa and cause significant bleeding, interferes with the endoscopic assessment and diagnostic procedures. Furthermore, skin irritation and infections caused by nasogastric procedures due to improper sterilization may restrain the demand for nasogastric tubes. Furthermore, high intensity of suction of these tubes during removal of gastric wastes can potentially damage gastric mucosa and result into bleeding would bean other hampering factor for the nasogastric tubes market.

Region Overview:

From 2022-2027, United States is estimated to witness robust growth prospects.

Company Overview

BD is one of the major players operating in the Nasogastric Tube market, holding a share of 41.16% in 2022.

BD

Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 70,000 people in more than 50 countries throughout the world. Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.

Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities.

Segmentation Overview:

By type, Levin tube segment accounted for the largest share of market in 2021.

Levin tube

Levin catheter, which is a single lumen, small bore NG tube. It is more appropriate for administration of medication or nutrition. Among various types of tubes available in the market, Salem sump catheter is predicted to gain faster demand in the near term. Furthermore, it could secure a handsome share of the market due to certain advantages over other tube types. It prevents the formation of inordinate vacuum at the tip of the tube because it carries a vent. Levin catheter segment will hold a significant revenue size over the forecast years due to its widespread usage in healthcare institutions, clinics, and hospitals. Levin catheters are comparatively safer tubes, with low complication rate. These tubes are available for single use that can reduce the infection rate and transmission of patient-to-patient infections. Levin tubes are made of thermo-stable material with smooth tip that lowers the insertion trauma. Such benefits associated with Levin catheter will escalate its adoption, thereby stimulating the segmental growth

Sengstaken-Blakemore tube

The Sengstaken-Blakemore (SB)tube is a red tube used to stop or slow bleeding from the esophagus and stomach. The bleeding is typically caused by gastric or esophageal varices, which are veins that have swollen from obstructed blood flow. A variation of the SB tube, called the Minnesota tube, can also be used to decompress or drain the stomach to avoid insertion of a second tube called a nasogastric tube.

Application Overview:

The market's largest segment by application is the segment Adult Use, with a market share of 72.82% in 2021.

Key Companies in the global Nasogastric Tube market covered in Chapter 3:

Q Holding Company
Pacific Hospital Supply
Rontis
Cardinal Health
GBUK Group Ltd.
Avanos
Bicakcilar
Andersen Products
Guangdong Baihe Medical Technology
BD

In Chapter 4 and Chapter 14.2, on the basis of types, the Nasogastric Tube market from 2018 to 2029 is primarily split into:

Levin Tube
Sengstaken-Blakemore Tube

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Nasogastric Tube market from 2018 to 2029 covers:

Children Use
Adult Use

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)